Merck & Co., Inc.
NYSEMerck & Co. heads into Tuesday's Q2 earnings call with the Street's bullish revision cycle still running, short sellers largely gone, and peers under pressure — leaving the stock to stand on its fundamentals alone. The analyst picture heading into this print is unusually one-sided. Barclays raised its target from $140 to $150 just three days before the report, maintaining Overweight…
MRK short interest plummets 22.8% in a week to just 0.99% of float—lowest level in months as bulls dominate ahead of August 4 earnings.
A new long-form analysis for MRK this week — anomalies vs the company's own history, peer comparisons, news context, and the full data picture. Premium subscribers only.
Read on ORTEX →Sign up for premiumMerck & Co. heads into Tuesday's Q2 earnings call with the Street's bullish revision cycle still running, short sellers largely gone, and peers under pressure — leaving the stock to stand on its fundamentals alone. The…
Snapshot as of 5 Aug 2026
Merck & Co. enters its August 4 Q2 earnings call with Barclays lifting its target to $150 that same morning — the most bullish Street action yet in a month of relentless upward revisions. The analyst tide has been…
Merck & Co. has given back ground sharply this week, falling 6.3% to $120.78 — yet analysts responded by raising price targets, not cutting them, creating the clearest tension in the MRK story right now. The stock's…
Merck & Co. is consolidating around the Street consensus after a strong month, with Wells Fargo lifting its target today and options traders remaining more bullish than their recent habit. The most active data point…
MRK reported Q1 earnings on May 26. The stock slipped 1.8% on the day. Two days later, options traders are still the most defensively positioned they've been all year. The put/call ratio stands at 0.93 — a fresh…
MRK arrives at Tuesday's Q1 print in a materially different position than it occupied three days ago — the stock has surged 10% over the past week to $122.41, yet options traders have not unwound their defensive…
MRK enters next week's Q1 results — scheduled for May 26 — with options positioning at the most cautious level recorded in the past twelve months. The clearest signal heading into the print is in the options market.…
MRK heads into its next earnings cycle with options traders growing more defensive even as short sellers trim positions — a divergence that defines the week's setup. The clearest signal this week comes from options.…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MRK — free to start on ORTEX.
Sign up for free →Open MRK on ORTEX